|
MTM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.847600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.683400E-03 |
| Normal-vs-Stage2 |
3.131600E-01 |
| Normal-vs-Stage3 |
5.572000E-01 |
| Normal-vs-Stage4 |
6.423200E-01 |
| Stage1-vs-Stage2 |
4.210200E-01 |
| Stage1-vs-Stage3 |
5.593500E-02 |
| Stage1-vs-Stage4 |
1.270630E-01 |
| Stage2-vs-Stage3 |
5.841400E-01 |
| Stage2-vs-Stage4 |
5.853000E-01 |
| Stage3-vs-Stage4 |
9.629800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.944000E-02 |
| Normal-vs-AfricanAmerican |
1.898120E-02 |
| Normal-vs-Asian |
2.008000E-01 |
| Caucasian-vs-AfricanAmerican |
9.495800E-02 |
| Caucasian-vs-Asian |
8.937800E-01 |
| AfricanAmerican-vs-Asian |
1.159380E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.926600E-01 |
| Normal-vs-Female |
1.242340E-02 |
| Male-vs-Female |
1.240170E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.139600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.226030E-01 |
| Normal-vs-Age(61-80Yrs) |
3.986600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.061600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.338570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.170400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.870400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.978200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.474380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.058800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.305800E-01 |
| Classical-VS-Follicular |
1.452340E-02 |
| Classical-VS-Other |
5.994300E-02 |
| Classical-VS-Normal |
1.824700E-03 |
| Tall-VS-Follicular |
9.094000E-01 |
| Tall-VS-Other |
2.048800E-01 |
| Tall-VS-Normal |
6.646400E-01 |
| Follicular-VS-Other |
3.299400E-01 |
| Follicular-VS-Normal |
7.345400E-01 |
| Other-VS-Normal |
2.125800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.480190E-01 |
| Normal-vs-N1 |
7.859200E-01 |
| N0-vs-N1 |
4.556800E-01 |
|
|
